Skip to content

13F-HR filed by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-04-19, with 104 holding rows worth $631,470,000.

Accession
0001415889-17-000651
Filed
2017-04-19
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2017

A holdings report, 104 entries on the cover page, a total value of $631,470,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $631,470,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HORIZON PHARMA PLCG4617B105SHS1,751,322$25,885,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock543,347$19,186,000thousands by filing date
BIOGEN INC COM09062X103Stock68,000$18,593,000thousands by filing date
GLAUKOS CORP COM377322102Stock325,800$16,714,000thousands by filing date
Amgen Inc.031162100COM100,000$16,407,000thousands by filing date
INCYTE CORP COM45337C102Stock115,000$15,372,000thousands by filing date
ABIOMED INC003654100COM117,048$14,654,000thousands by filing date
Medtronic PlcG5960L103COM181,115$14,591,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock37,000$14,338,000thousands by filing date
Eli Lilly and Company532457108COM170,000$14,299,000thousands by filing date
ALLERGAN PLCG0177J108SHS59,000$14,096,000thousands by filing date
Gilead Sciences,Inc.375558103COM206,916$14,054,000thousands by filing date
EXELIXIS INC COM30161Q104Stock630,000$13,652,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM111,702$13,543,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK715,664$11,630,000thousands by filing date
ENDOLOGIX INC29266S106COM1,600,000$11,584,000thousands by filing date
CELGENE CORP151020104COM93,000$11,572,000thousands by filing date
Pfizer Inc.717081103COM335,422$11,475,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM470,000$11,031,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM125,000$10,973,000thousands by filing date
Bristol-Myers Squibb Company110122108COM201,000$10,930,000thousands by filing date
UnitedHealth Group Inc91324P102COM65,000$10,661,000thousands by filing date
NEVRO CORP64157F103COM112,614$10,552,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM95,013$10,390,000thousands by filing date
CVS Health Corporation126650100COM130,000$10,205,000thousands by filing date
Merck & Co.,Inc.58933Y105COM160,000$10,166,000thousands by filing date
CIGNA CORPORATION125509109COM64,000$9,375,000thousands by filing date
HCA Healthcare Inc40412C101COM104,707$9,318,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock60,320$8,754,000thousands by filing date
KITE PHARMA INC49803L109COM110,000$8,634,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock70,000$8,548,000thousands by filing date
AbbVie,Inc.00287Y109COM130,000$8,471,000thousands by filing date
ALKERMES PLCG01767105SHS140,409$8,214,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM230,000$7,199,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock130,000$6,663,000thousands by filing date
AETNA INC NEW00817Y108COM52,000$6,633,000thousands by filing date
HUMANA INC COM444859102Stock32,000$6,596,000thousands by filing date
HOLOGIC INC436440101COM150,000$6,383,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM96,000$6,327,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock87,593$6,242,000thousands by filing date
XENCOR INC98401F105COMMON STOCK260,000$6,219,000thousands by filing date
Elevance Health, Inc.036752103COM37,468$6,196,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM40,000$6,144,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM75,000$6,116,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW984,696$5,859,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock60,000$5,644,000thousands by filing date
CENCORA INC COM03073E105Stock63,000$5,576,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM72,659$5,164,000thousands by filing date
Abbott Laboratories002824100COM115,000$5,107,000thousands by filing date
Lion Biotechnologies53619R102COM650,000$4,843,000thousands by filing date
DEXCOM INC COM252131107Stock56,900$4,821,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock120,805$4,734,000thousands by filing date
ENDO INTL PLCG30401106SHS402,303$4,490,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM210,000$4,368,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock35,000$4,356,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,282,000$4,243,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK153,901$4,129,000thousands by filing date
OMNICELL COM COM68213N109Stock98,537$4,006,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM85,000$3,855,000thousands by filing date
FIBROGEN INC31572Q808COM154,341$3,805,000thousands by filing date
DAVITA INC COM23918K108Stock55,000$3,738,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM45,000$3,737,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM85,000$3,681,000thousands by filing date
MYLAN NVN59465109SHS EURO90,000$3,509,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM30,000$3,393,000thousands by filing date
MACROGENICS INC556099109COM175,000$3,255,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock350,000$3,129,000thousands by filing date
IMMUNOMEDICS INC452907108COM479,610$3,103,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM90,000$3,094,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW21,550$3,092,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM4,000$3,066,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW75,000$2,899,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK300,000$2,757,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM155,000$2,713,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK425,111$2,619,000thousands by filing date
CHIMERIX INC COM16934W106Stock400,000$2,552,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM111,357$2,355,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock170,000$2,203,000thousands by filing date
BIOVERATIV INC09075E100COM31,000$1,688,000thousands by filing date
INSULET CORP COM45784P101Stock35,000$1,508,000thousands by filing date
REGULUS THERAPEUTICS INC75915K101COM593,629$979,000thousands by filing date
BECTON DICKINSON & CO075887109COM5,000$917,000thousands by filing date
TESARO INC881569107COM5,000$769,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM166,000$699,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM30,099$513,000thousands by filing date
CATABASIS PHARMACEUTICALS IN14875P107COM310,756$497,000thousands by filing date
JPMorgan Chase & Co46625H100COM4,837$425,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock154,006$416,000thousands by filing date
OREXIGEN THERAPEUTICS INC COM NEW686164302Stock120,000$413,000thousands by filing date
Wells Fargo & Company949746101COM7,305$407,000thousands by filing date
EXXON MOBIL CORP30231G102COM4,823$396,000thousands by filing date
HALLIBURTON CO COM406216101Stock7,718$380,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM40,000$371,000thousands by filing date
Microsoft Corp594918104COM4,793$316,000thousands by filing date
International Business Machines Corporation459200101COM1,766$308,000thousands by filing date
Qualcomm Incorporated747525103COM5,368$308,000thousands by filing date
ANHEUSER BUSCH INBEV SA NV SPONSORED ADR03524A108ADR2,806$308,000thousands by filing date
STAAR SURGICAL CO COM PAR $0.01852312305Stock28,711$281,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM234,000$281,000thousands by filing date
FORD MTR CO COM345370860Stock22,511$262,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM50,000$260,000thousands by filing date
THRESHOLD PHARMACEUTICAL INC885807206COM NEW201,537$115,000thousands by filing date
OPHTHOTECH CORP683745103COM23,920$88,000thousands by filing date
ANTHERA PHARMACEUTCLS INC03674U201Common equity shares200,000$85,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001415889-17-000651this filing2017-04-19acceptance time not in the bulk data set